SEC Form 4 · accession 0001209191-15-020355
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald W DeGolyer
Officer — Chief Operating Officer,Pharma
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Feb 26, 2015 | F | 477 | $85.19 | D | 6,547 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Mr. DeGolyer's February 26, 2014 grant of restricted stock units (RSUs) vested on February 26, 2015. Upon vesting, certain shares were withheld by the issuer to satisfy tax obligations on shares acquired.
- F2These shares represent stock withheld by the issuer to satisfy tax withholding obligations on shares acquired upon vesting of RSUs.
- F3$85.19 represents the vesting price, which is the average of the high and low share price on February 26, 2015.